The EPO published European patent application EP3494213A1 for Wake Forest University Health Sciences relating to a 3D blood-brain barrier model. The patent covers methods of creating and using an in vitro model that simulates the blood-brain barrier for drug testing and research applications. IPC classifications indicate applications in cell culture technology, organ/tissue preparations, and biological preparations related to the circulatory and nervous systems.

This is a patent grant publication rather than a regulatory action imposing compliance obligations. No deadlines, required actions, or penalties apply. Companies developing neurological drugs or conducting blood-brain barrier research should review the patent claims to assess potential licensing needs or freedom-to-operate considerations.